BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26989202)

  • 1. Optimizing therapy for nodal marginal zone lymphoma.
    Thieblemont C; Molina T; Davi F
    Blood; 2016 Apr; 127(17):2064-71. PubMed ID: 26989202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):371-378. PubMed ID: 29222281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
    Spina V; Rossi D
    Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic marginal zone lymphoma: from genetics to management.
    Arcaini L; Rossi D; Paulli M
    Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
    Tadmor T; Polliack A
    Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of nodal marginal zone lymphoma.
    Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
    Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
    Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
    Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
    Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
    Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood nodal marginal zone lymphoma with unusual clinicopathologic and cytogenetic features for the pediatric variant: a case report.
    Aqil B; Merritt BY; Elghetany MT; Kamdar KY; Lu XY; Curry CV
    Pediatr Dev Pathol; 2015; 18(2):167-71. PubMed ID: 25625642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profiling of low-grade and transformed nodal marginal zone lymphoma reveals a similar signature pattern distinct from diffuse large B cell lymphoma.
    Gebauer N; Thorns C; Bernard V; Senft A; Schillert A; Merz H; Feller AC; Bernd HW
    Acta Haematol; 2015; 133(2):214-20. PubMed ID: 25376122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal marginal zone lymphoma.
    Angelopoulou MK; Kalpadakis C; Pangalis GA; Kyrtsonis MC; Vassilakopoulos TP
    Leuk Lymphoma; 2014 Jun; 55(6):1240-50. PubMed ID: 24004184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.
    Arribas AJ; Campos-Martín Y; Gómez-Abad C; Algara P; Sánchez-Beato M; Rodriguez-Pinilla MS; Montes-Moreno S; Martinez N; Alves-Ferreira J; Piris MA; Mollejo M
    Blood; 2012 Jan; 119(3):e9-e21. PubMed ID: 22110251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
    Juárez-Salcedo LM; Castillo JJ
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Floral leukemic cells transformed from marginal zone lymphoma.
    Chang ST; Hsieh YC; Lu YH; Tzeng CC; Lin CN; Chuang SS
    Pathol Res Pract; 2008; 204(1):23-6. PubMed ID: 17913385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric nodal marginal zone lymphoma may develop in the adult population.
    Gitelson E; Al-Saleem T; Robu V; Millenson MM; Smith MR
    Leuk Lymphoma; 2010 Jan; 51(1):89-94. PubMed ID: 19863176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
    Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
    Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
    Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
    Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.